Showing results (221-230 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|October 23, 2019
Age-specific associations between HIV infection and carotid artery intima-media thickness in China: a cross-sectional evaluation of baseline data from the CHART cohortHaijiang Lin, Yingying Ding, Chenxi Ning, et al.
The Lancet. HIV|September 12, 2021
Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trialJoan T Price, Bellington Vwalika, Bethany L Freeman, et al.
The Lancet. HIV|April 29, 2021
Overview of SARS-CoV-2 infection in adults living with HIVJuan Ambrosioni, José Luis Blanco, Juliana M Reyes-Urueña, et al.
The Lancet. HIV|September 5, 2025
HIV-related mortality time trends among children and young adolescents on antiretroviral therapy by age, treatment duration, and region: a systematic review and meta-regression analysisJiawei He, Edmond Brewer, Amanda Novotney, et al.
The Lancet. HIV|June 5, 2020
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trialRaphael J Landovitz, Sue Li, Joseph J Eron, et al.
The Lancet. HIV|June 7, 2020
Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trialKathleen E Wirth, Tendani Gaolathe, Molly Pretorius Holme, et al.
The Lancet. HIV|May 17, 2021
Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trialJean-Michel Molina, Yazdan Yazdanpanah, Alejandro Afani Saud, et al.
The Lancet. HIV|May 24, 2021
A tale of four studies: HIV vaccine immunogenicity and efficacy in clinical trialsSusan Zolla-Pazner, Nelson L Michael, Jerome H Kim
The Lancet. HIV|August 9, 2021
Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six citiesAmanda My Linh Quan, Cassandra Mah, Emanuel Krebs, et al.
The Lancet. HIV|December 20, 2016
Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysisVivek Jain, Maya L Petersen, Teri Liegler, et al.
Pageof 79